Shem Patyna

Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors

Éric Raymond, Laëtitia Dahan, Jean‐Luc Raoul et al. · New England Journal of Medicine · 2011 · 2.5K citations

Effect of the Multitargeted Tyrosine Kinase Inhibitors Imatinib, Dasatinib, Sunitinib, and Sorafenib on Mitochondrial Function in Isolated Rat Heart Mitochondria and H9c2 Cells

Yvonne Will, James A. Dykens, Sashi Nadanaciva et al. · Toxicological Sciences · 2008 · 213 citations

Cardiovascular Toxicity, Mitophagy, Mitochondrial Disease +12

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study

Sandrine Faivre, Patricia Niccoli, Daniel Castellano et al. · Annals of Oncology · 2016 · 189 citations · Full text

Neuro-oncology, Progression-free Survival, Pancreatic Cancer +10

Electrocardiographic Characterization of the QTc Interval in Patients with Advanced Solid Tumors: Pharmacokinetic- Pharmacodynamic Evaluation of Sunitinib

Carlo L. Bello, Marilyn Mulay, Xin Huang et al. · Clinical Cancer Research · 2009 · 103 citations

SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity

Shem Patyna, Alexander Laird, Dirk B. Mendel et al. · Molecular Cancer Therapeutics · 2006 · 102 citations